<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01592552</url>
  </required_header>
  <id_info>
    <org_study_id>SAN-ND-01</org_study_id>
    <nct_id>NCT01592552</nct_id>
  </id_info>
  <brief_title>A Biospecimen and Clinical Data Study on Patients With Alzheimer's, Multiple Sclerosis, Parkinson's, and Huntington's, for Drug &amp; Biomarker Discovery</brief_title>
  <official_title>A Multi-Center Longitudinal Biorepository Study to Provide Biospecimens &amp; Clinical Data From Neurological Disease Patients To Approved Pre-Clinical And Clinical Investigators for Drug &amp; Biomarker Studies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanguine Biosciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanguine Biosciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research project is to collect and store blood samples and clinical data.
      Researchers can then use the stored samples in future studies. Through such studies, they
      hope to find new ways to detect, treat, and maybe even prevent or cure health problems.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Blood samples are collected in the comfort and safety of your home by a certified medical
      professional. We have mobile phlebotomists located in major metropolitan areas around the
      nation for your convenience.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Biospecimens &amp; Clinical Data collection from patients with neurological diseases.</measure>
    <time_frame>2 years</time_frame>
    <description>The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Alzheimer's Disease</condition>
  <condition>Multiple Sclerosis</condition>
  <condition>Parkinson's Disease</condition>
  <condition>Huntington's Disease</condition>
  <condition>Amyotrophic Lateral Sclerosis (ALS)</condition>
  <arm_group>
    <arm_group_label>Neurological Condition</arm_group_label>
    <description>Collect blood and other biospecimens like saliva, urine and CSF for research purposes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Collect blood and other biospecimens like saliva, urine and CSF for research purposes.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        A diagnosis of Multiple Sclerosis, Alzheimer's, Huntington's, or Parkinson's Disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females &gt;18 to 100 years old

          -  A diagnosis of neurological condition

          -  Proof of diagnosis can be provided

        Control group: Healthy donors, males and females, 18 to 100 years of age

        Exclusion Criteria

          -  Receipt of blood products within 30 days of study enrollment

          -  Receipt of an investigational (unapproved) drug within 30 days of study enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlyn Crisostomo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sanguine Biosciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanguine Biosciences</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>91403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2011</study_first_submitted>
  <study_first_submitted_qc>May 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2012</study_first_posted>
  <last_update_submitted>March 1, 2016</last_update_submitted>
  <last_update_submitted_qc>March 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alzheimer's Disease</keyword>
  <keyword>Multiple Sclerosis</keyword>
  <keyword>Parkinson's Disease</keyword>
  <keyword>Huntington's Disease</keyword>
  <keyword>Amyotrophic Lateral Sclerosis (ALS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Huntington Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

